BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9309765)

  • 21. Polyamine transport in parasites: a potential target for new antiparasitic drug development.
    Reguera RM; Tekwani BL; Balaña-Fouce R
    Comp Biochem Physiol C Toxicol Pharmacol; 2005 Feb; 140(2):151-64. PubMed ID: 15907761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug therapy of gastrointestinal parasitic infections. The ACG Committee of FDA-related matters.
    Turner JA
    Am J Gastroenterol; 1986 Dec; 81(12):1125-37. PubMed ID: 3538852
    [No Abstract]   [Full Text] [Related]  

  • 23. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiparasitic evaluation of a new antibiotic.
    Kohls RE; Bradley RE
    J Parasitol; 1970 Jun; 56(3):615-6. PubMed ID: 5421094
    [No Abstract]   [Full Text] [Related]  

  • 25. New approaches for the identification of drug targets in protozoan parasites.
    Müller J; Hemphill A
    Int Rev Cell Mol Biol; 2013; 301():359-401. PubMed ID: 23317822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in drug discovery and biochemical studies.
    Kita K; Shiomi K; Omura S
    Trends Parasitol; 2007 May; 23(5):223-9. PubMed ID: 17383234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic filtering: an approach to discovering novel antiparasitics.
    McCarter JP
    Trends Parasitol; 2004 Oct; 20(10):462-8. PubMed ID: 15363439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opportunities and challenges in antiparasitic drug discovery.
    Pink R; Hudson A; Mouriès MA; Bendig M
    Nat Rev Drug Discov; 2005 Sep; 4(9):727-40. PubMed ID: 16138106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multiparameter analysis approach of antiparasitic structure-activity relationships in function of the parasite taxonomy].
    Lacroix J; Doré JC; el Alami J; Reynouard F; Viel C; Lacroix R
    Ann Pharm Fr; 1989; 47(6):383-93. PubMed ID: 2488252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perspectives and important needs in parasite chemotherapy.
    Thompson PE
    J Parasitol; 1971 Feb; 57(1):3-8. PubMed ID: 4994805
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of antiprotozoan and anthelmintic drugs during pregnancy: side-effects and contra-indications.
    Cook GC
    J Infect; 1992 Jul; 25(1):1-9. PubMed ID: 1522314
    [No Abstract]   [Full Text] [Related]  

  • 32. Phosphonoxins: rational design and discovery of a potent nucleotide anti-Giardia agent.
    Suk DH; Rejman D; Dykstra CC; Pohl R; Pankiewicz KW; Patterson SE
    Bioorg Med Chem Lett; 2007 May; 17(10):2811-6. PubMed ID: 17360182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drugs for protozoan diseases].
    Ohta N
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():380-3. PubMed ID: 17455649
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiparasitic properties of medicinal plants and other naturally occurring products.
    Tagboto S; Townson S
    Adv Parasitol; 2001; 50():199-295. PubMed ID: 11757332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of anthelmintics, antiprotozoal drugs and ectoparasiticides for racing pigeons (Columba livia var. domestica) available in The Netherlands.
    Zwijnenberg RJ; Vulto AG; van Miert AS; Lumeij JT
    J Vet Pharmacol Ther; 1992 Dec; 15(4):395-408. PubMed ID: 1487838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The challenges of developing novel antiparasitic drugs.
    Woods DJ; Williams TM
    Invert Neurosci; 2007 Dec; 7(4):245-50. PubMed ID: 18004600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections.
    Feng L; Pomel S; Latre de Late P; Taravaud A; Loiseau PM; Maes L; Cho-Ngwa F; Bulman CA; Fischer C; Sakanari JA; Ziniel PD; Williams DL; Davioud-Charvet E
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33139647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global trends in the pharmaceutical industry.
    Albers-Schönberg G
    P R Health Sci J; 2002 Jun; 21(2):85-9. PubMed ID: 12166029
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiparasitic drugs.
    Yoshikawa TT
    Am Fam Physician; 1980 Mar; 21(3):132-8. PubMed ID: 7355683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of drugs against significant parasitic diseases in domestic animals. I. Possibilities and principles of parasite control; cattle: piroplasmosis and coccidiosis].
    Hiepe T; Ribbeck R
    Monatsh Veterinarmed; 1966 Feb; 21(4):151-4. PubMed ID: 5973887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.